Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Hyo Jin Maeng"'
Publikováno v:
Endocrinology and Metabolism, Vol 36, Iss 1, Pp 157-170 (2021)
Background Glucagon-like peptide-1 (GLP-1) analogues regulate glucose homeostasis and have anti-inflammatory properties, but cause gastrointestinal side effects. The fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose met
Externí odkaz:
https://doaj.org/article/76e2b518efaf4996beb3aa0b6f7ca206
Publikováno v:
Journal of Obesity & Metabolic Syndrome, Vol 29, Iss 1, Pp 26-38 (2020)
Background : : Growing evidence suggests links between sugar-sweetened beverages (SSBs) and metabolic disorders. We investigated the effects of SSBs commonly consumed by adolescents and their relationships to glucose metabolism and fatty liver. Meth
Externí odkaz:
https://doaj.org/article/4d03e3ce27c744b1bc21c830a17cb744
Publikováno v:
Journal of Obesity & Metabolic Syndrome, Vol 31, Iss 1, Pp 91-91 (2022)
Externí odkaz:
https://doaj.org/article/fee819b8985d460780fca8329ebc5367
Autor:
Kyoung Min Kim, Hyun-Jin Jin, Seo Yeon Lee, Hyo Jin Maeng, Gha Young Lee, Tae Jung Oh, Sung Hee Choi, Hak Chul Jang, Soo Lim
Publikováno v:
Endocrinology and Metabolism, Vol 32, Iss 3, Pp 389-395 (2017)
BackgroundBone strength is impaired in patients with type 2 diabetes mellitus despite an increase in bone mineral density (BMD). Thiazolidinedione (TZD), a peroxisome proliferator activated receptor γ agonist, promotes adipogenesis, and suppresses o
Externí odkaz:
https://doaj.org/article/2350ddf1e51143b3a9dff13c083d7a55
Publikováno v:
Endocrinology and Metabolism
Endocrinology and Metabolism, Vol 36, Iss 1, Pp 157-170 (2021)
Endocrinology and Metabolism, Vol 36, Iss 1, Pp 157-170 (2021)
Background Glucagon-like peptide-1 (GLP-1) analogues regulate glucose homeostasis and have anti-inflammatory properties, but cause gastrointestinal side effects. The fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose met
Publikováno v:
Journal of Obesity & Metabolic Syndrome, Vol 29, Iss 1, Pp 26-38 (2020)
Journal of Obesity & Metabolic Syndrome
Journal of Obesity & Metabolic Syndrome
Background : : Growing evidence suggests links between sugar-sweetened beverages (SSBs) and metabolic disorders. We investigated the effects of SSBs commonly consumed by adolescents and their relationships to glucose metabolism and fatty liver. Metho
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 18
International Journal of Molecular Sciences, Vol 21, Iss 6836, p 6836 (2020)
Volume 21
Issue 18
International Journal of Molecular Sciences, Vol 21, Iss 6836, p 6836 (2020)
Fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose metabolism. We aimed to investigate the effect of an FGF21 analogue (LY2405319) on the development of atherosclerosis and its associated parameters. ApoE&minus
/&mi
/&mi
Autor:
Hyo Jin Maeng, Hyeree Yu, Bo Rahm Kim, Tae Jung Oh, Kyoung Min Kim, Sung Hee Choi, Soo Lim, Gha Young Lee, Jae Hoon Moon, Hak Chul Jang
Publikováno v:
Biochemical and Biophysical Research Communications. 497:1149-1153
Adipogenesis is the process of differentiation from preadipocytes to adipocytes and is orchestrated by various transcription factors, such as the peroxisome proliferator-activated receptor gamma (PPARγ) and the CCAAT-enhancer-binding protein alpha (
Autor:
Hyo Jin Maeng, Gha Young Lee, Soo Lim, Hyun Jin Jin, Seo Yeon Lee, Kyoung Min Kim, Tae Jung Oh, Sung Hee Choi, Hak Chul Jang
Publikováno v:
Endocrinology and Metabolism, Vol 32, Iss 3, Pp 389-395 (2017)
Endocrinology and Metabolism
Endocrinology and Metabolism
Background Bone strength is impaired in patients with type 2 diabetes mellitus despite an increase in bone mineral density (BMD). Thiazolidinedione (TZD), a peroxisome proliferator activated receptor γ agonist, promotes adipogenesis, and suppresses
Autor:
Kangpa Lee, Tae-Sik Park, Jae-Hwi Song, Goon-Tae Kim, Jaeyoung Kim, Yoo-Jeong Song, Hyo Jin Maeng
Publikováno v:
BMB Reports
BMB REPORTS(50): 3
BMB REPORTS(50): 3
Ceramides are the major sphingolipid metabolites involved in cell survival and apoptosis. When HepG2 hepatoma cells were treated with celecoxib, the expression of the genes in de novo sphingolipid biosynthesis and sphingomyelinase pathway was upregul